Health Catalyst, Inc. (HCAT)

Health Catalyst Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	316.09	306.58	295.94	276.24	241.93	188.85
Revenue Growth (YoY)	5.55%	3.60%	7.13%	14.18%	28.11%	21.88%
Cost of Revenue	170.68	164.79	161.11	140.68	124.17	98.08
Gross Profit	145.41	141.79	134.83	135.56	117.76	90.77
Selling, General & Admin	98.18	100.65	111.06	144.37	132.32	96.5
Research & Development	54.23	56.8	68.5	69.23	61.83	53.52
Operating Expenses	197.67	198.89	221.78	261.89	231.68	168.74
Operating Income	-52.26	-57.1	-86.96	-126.33	-113.92	-77.97
Interest Expense	-26.53	-17.09	-7.29	-1.68	-	-11.57
Interest & Investment Income	15.07	17.98	16.39	-	-	-
Other Non Operating Income (Expenses)	0.23	-0.26	0	-	-16.46	-
EBT Excluding Unusual Items	-63.48	-56.46	-77.85	-128.01	-130.38	-89.54
Merger & Restructuring Charges	-14.24	-12.15	-14.58	-13.32	-7.89	-2.67
Asset Writedown	-	-2.2	-4.08	-5.02	-1.8	-
Legal Settlements	-	-	-21.28	-	-	-
Other Unusual Items	6.81	1.64	-	4.67	-20.04	-24
Pretax Income	-99.67	-69.17	-117.79	-141.68	-160.11	-116.21
Income Tax Expense	0.45	0.33	0.36	-4.28	-6.9	-1.19
Earnings From Continuing Operations	-	-69.5	-118.15	-137.4	-153.21	-115.02
Net Income	-100.12	-69.5	-118.15	-137.4	-153.21	-115.02
Net Income to Common	-100.12	-69.5	-118.15	-137.4	-153.21	-115.02
Shares Outstanding (Basic)	65	60	56	54	47	40
Shares Outstanding (Diluted)	65	60	56	54	47	40
Shares Change (YoY)	12.46%	6.68%	4.32%	13.87%	20.12%	110.98%
EPS (Basic)	-1.53	-1.15	-2.09	-2.56	-3.23	-2.91
EPS (Diluted)	-1.53	-1.15	-2.09	-2.63	-3.23	-2.91
Free Cash Flow	-7.59	12.94	-34.32	-37.44	-33.57	-33.92
Free Cash Flow Per Share	-0.12	0.21	-0.61	-0.69	-0.71	-0.86
Gross Margin	46.00%	46.25%	45.56%	49.07%	48.68%	48.07%
Operating Margin	-16.53%	-18.62%	-29.38%	-45.73%	-47.09%	-41.29%
Profit Margin	-31.67%	-22.67%	-39.92%	-49.74%	-63.33%	-60.91%
Free Cash Flow Margin	-2.40%	4.22%	-11.60%	-13.55%	-13.88%	-17.96%
EBITDA	-17.9	-25.37	-53.24	-84.83	-78.79	-59.94
EBITDA Margin	-5.66%	-8.27%	-17.99%	-30.71%	-32.57%	-31.74%
D&A For EBITDA	34.35	31.73	33.72	41.5	35.13	18.03
EBIT	-52.26	-57.1	-86.96	-126.33	-113.92	-77.97
EBIT Margin	-16.53%	-18.62%	-29.38%	-45.73%	-47.09%	-41.29%
Revenue as Reported	316.09	306.58	295.94	276.24	241.93	188.85
Advertising Expenses	-	5.1	2.6	5.7	4.4	4.3

Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q